Literature DB >> 10072436

Genetic mapping of a maternal locus responsible for familial hydatidiform moles.

Y B Moglabey1, R Kircheisen, M Seoud, N El Mogharbel, I Van den Veyver, R Slim.   

Abstract

Hydatidiform mole (HM) is the product of an aberrant human pregnancy in which there is an abnormal embryonic development and proliferation of placental villi. The incidence of HM varies between ethnic groups, and occurs in 1 in every 1500 pregnancies in the USA. All HM cases are sporadic, except for extremely rare familial cases. The exact mechanisms leading to molar pregnancies are unknown. We previously postulated that women with recurrent hydatidiform moles are homozygous for an autosomal recessive defective gene. To map this gene genetically, we initiated a genome-wide scan with highly polymorphic short tandem repeats in individuals from two families with recurrent HM. Here, we demonstrate that a defective maternal gene is responsible for recurrent HM. This gene resides on chromosome 19q13.3-13.4 in a 15.2 cM interval flanked by D19S924 and D19S890. The identification of a gene for HM adds new insights into the molecular genetics of early embryogenesis and may be relevant to the large number of patients with sporadic HM.

Entities:  

Mesh:

Year:  1999        PMID: 10072436     DOI: 10.1093/hmg/8.4.667

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

Review 1.  Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review.

Authors:  Ioannis Kalogiannidis; Kallirhoe Kalinderi; Michail Kalinderis; Dimosthenis Miliaras; Basil Tarlatzis; Apostolos Athanasiadis
Journal:  J Assist Reprod Genet       Date:  2018-05-08       Impact factor: 3.412

2.  No evidence for mutations in NLRP7 and KHDC3L in women with androgenetic hydatidiform moles.

Authors:  Sangeetha Mahadevan; Shu Wen; Alfred Balasa; Gary Fruhman; Julio Mateus; Andrew Wagner; Tarek Al-Hussaini; Ignatia B Van den Veyver
Journal:  Prenat Diagn       Date:  2013-10-04       Impact factor: 3.050

3.  Recurrent familial hydatidiform mole - a rare clinical problem.

Authors:  Lavanya Rai; Hebbar Shripad; Shyamala Guruvayare; Adiga Prashant; Anjali Sunil
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

4.  Recurrent hydatidiform mole: A case report of six consecutive molar pregnancies complicated by choriocarcinoma, and review of the literature.

Authors:  Ahlam A Al-Ghamdi
Journal:  J Family Community Med       Date:  2011-09

Review 5.  NLRP7: From inflammasome regulation to human disease.

Authors:  Jessica Carriere; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunology       Date:  2021-06-30       Impact factor: 7.215

6.  Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion.

Authors:  Kristen K Rumer; Miriam D Post; Rhea S Larivee; Martina Zink; Jill Uyenishi; Anita Kramer; Deanna Teoh; Kevin Bogart; Virginia D Winn
Journal:  Endocr Relat Cancer       Date:  2012-11-19       Impact factor: 5.678

7.  NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges.

Authors:  Rima Slim; Evan P Wallace
Journal:  Front Immunol       Date:  2013-08-20       Impact factor: 7.561

8.  Germline mutation in NLRP2 (NALP2) in a familial imprinting disorder (Beckwith-Wiedemann Syndrome).

Authors:  Esther Meyer; Derek Lim; Shanaz Pasha; Louise J Tee; Fatimah Rahman; John R W Yates; C Geoffrey Woods; Wolf Reik; Eamonn R Maher
Journal:  PLoS Genet       Date:  2009-03-20       Impact factor: 5.917

9.  Lack of involvement of known DNA methyltransferases in familial hydatidiform mole implies the involvement of other factors in establishment of imprinting in the human female germline.

Authors:  B E Hayward; M De Vos; H Judson; D Hodge; J Huntriss; H M Picton; E Sheridan; D T Bonthron
Journal:  BMC Genet       Date:  2003-01-20       Impact factor: 2.797

10.  Patterns of hybrid loss of imprinting reveal tissue- and cluster-specific regulation.

Authors:  Christopher D Wiley; Harry H Matundan; Amanda R Duselis; Alison T Isaacs; Paul B Vrana
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.